Published in Cancer on August 01, 2001
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet (2009) 2.02
ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer (2006) 1.47
Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res (2011) 1.36
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. J Cancer Res Clin Oncol (2008) 1.13
Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines. Cell Cycle (2014) 1.10
The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat (2006) 1.09
Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis. Hum Mutat (2009) 1.08
ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Br J Cancer (2003) 1.00
Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res (2008) 1.00
Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice. Breast Cancer Res (2004) 0.94
Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study. Breast Cancer Res (2004) 0.94
Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study. Breast Cancer Res (2006) 0.93
Mutation analysis of the ATR gene in breast and ovarian cancer families. Breast Cancer Res (2005) 0.83
No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res (2002) 0.83
Is PML a Tumor Suppressor? Front Oncol (2013) 0.82
Multifunctional role of ATM/Tel1 kinase in genome stability: from the DNA damage response to telomere maintenance. Biomed Res Int (2014) 0.80
Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002. Breast Cancer Res (2002) 0.78
DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry. Anticancer Res (2016) 0.75
Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor? Transl Gastroenterol Hepatol (2016) 0.75
[Hereditary breast and ovarian cancers]. Pathologe (2010) 0.75
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Ovarian tumors in a cohort of infertile women. N Engl J Med (1994) 4.91
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell (1998) 4.72
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev (1988) 4.23
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med (1997) 4.21
Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet (1999) 3.95
BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med (1996) 3.83
Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature (1988) 3.82
ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet (2000) 3.49
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc Natl Acad Sci U S A (1998) 2.81
Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst (2001) 2.73
DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell (2001) 2.69
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.58
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51
Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst (1994) 2.51
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA (1995) 2.43
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst (1995) 2.36
Clinical characteristics of different histologic types of breast cancer. Br J Cancer (2005) 2.36
Patterns of differentiation and hybridization in North American wolflike canids, revealed by analysis of microsatellite loci. Mol Biol Evol (1994) 2.28
Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet (1999) 2.26
Characteristics of women with and without breast augmentation. JAMA (1997) 2.26
Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer (2001) 2.25
Diversity and structure of human T-cell receptor beta-chain variable region genes. Proc Natl Acad Sci U S A (1986) 2.19
Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res (1997) 2.18
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol (2001) 2.18
Regulated genomic instability and neoplasia in the lymphoid lineage. Blood (1999) 2.13
Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet (1999) 2.12
Risk factors for sudden infant death syndrome: changes associated with sleep position recommendations. J Pediatr (2001) 2.09
Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am J Hum Genet (1995) 2.07
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer (2005) 1.96
Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst (2001) 1.95
Correlates of homosexual behavior and the incidence of anal cancer. JAMA (1982) 1.95
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res (2001) 1.89
Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomes. Genome Res (2001) 1.88
A second-generation genetic linkage map of the domestic dog, Canis familiaris. Genetics (1999) 1.85
Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol (2001) 1.85
Molecular genetics of the most endangered canid: the Ethiopian wolf Canis simensis. Mol Ecol (1994) 1.85
An integrated linkage-radiation hybrid map of the canine genome. Mamm Genome (2000) 1.84
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer (2000) 1.83
Perinatal factors and risk of breast cancer. Epidemiology (1996) 1.82
Case-control differences in the reliability of reporting a history of induced abortion. Am J Epidemiol (2000) 1.82
Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer (1999) 1.82
A class of highly polymorphic tetranucleotide repeats for canine genetic mapping. Mamm Genome (1996) 1.77
Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology (1997) 1.76
Prenatal care and pregnancy outcomes during the recession: the Washington State experience. Am J Public Health (1985) 1.76
Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer (2000) 1.75
Body size and breast cancer risk among women under age 45 years. Am J Epidemiol (1996) 1.75
Rising incidence of breast cancer among young women in Washington State. J Natl Cancer Inst (1987) 1.74
Distinct functional domains of nibrin mediate Mre11 binding, focus formation, and nuclear localization. Mol Cell Biol (2001) 1.73
Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72
Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation (1996) 1.72
Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg (2001) 1.71
Infant mortality among subsequent siblings of infants who died of sudden infant death syndrome. J Pediatr (1986) 1.70
Diversity and structure of human T-cell receptor alpha-chain variable region genes. Proc Natl Acad Sci U S A (1987) 1.69
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
Use of electric blankets and risk of testicular cancer. Am J Epidemiol (1990) 1.69
Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med (1985) 1.69
Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet (1997) 1.68
Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum (1993) 1.64
Recreational drug use and the risk of primary infertility. Epidemiology (1990) 1.64
Epidemiology of ectopic pregnancy. Epidemiol Rev (1987) 1.62
An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst) (2004) 1.60
A linkage map of the canine genome. Genomics (1997) 1.56
Induced abortion and subsequent outcome of pregnancy in a series of American women. N Engl J Med (1977) 1.56
Vasectomy and the incidence of testicular cancer. Am J Epidemiol (1988) 1.55
Induced abortion and subsequent outcome of pregnancy. A matched cohort study. Lancet (1975) 1.55
The extent of the human germline T-cell receptor V beta gene segment repertoire. Immunogenetics (1994) 1.55
Conserved organization of the human and murine T-cell receptor beta-gene families. Nature (1988) 1.54
Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol (1984) 1.54
Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies. Teratology (1995) 1.53
History of lactation and breast cancer risk. Am J Epidemiol (1993) 1.52
Risk of breast cancer in a cohort of infertile women. Gynecol Oncol (1996) 1.51
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer (1997) 1.50
Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite. J Clin Epidemiol (1989) 1.50
Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst (1995) 1.50
Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab (1999) 1.50